search
Back to results

Cold EMR Vs Standard EMR for the Treatment of Large Nonpedunculated Homogeneous Colorectal Lesions

Primary Purpose

Adenoma Colon, Serrated Polyp, Serrated Adenoma

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Standard Endoscopic Mucosal Resection
Cold Snare Endoscopic Mucosal Resection
Sponsored by
Oscar Nogales
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Adenoma Colon focused on measuring endoscopic mucosal resection, cold snare endoscopic mucosal resection, standard endoscopic mucosal resection, large nonpedunculated homogeneous colorectal lesions, adenoma colon, serrated polyp, serrated adenoma, conventional endoscopic mucosal resection, laterally spreading adenomas.

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients of age > 18 years undergoing a colonoscopy for any reason of request and who do not meet exclusion criteria.
  • Nonpedunculated homogeneous colorectal lesions type LST ( Paris 0-IIa morphology) and serrated lesions larger than 20 mm without endoscopic data of malignancy: NICE 1 pattern +/- NICE 2 component ( serrated lesions) or NICE2 pattern/JNET 2A (adenomas) and therefore subsidiaries of RME. Randomization will be performed per patient, not for colorectal lesions
  • Signature of informed consent of endoscopic exploration

Exclusion Criteria:

  • .No signature of informed consent prior to the study procedure.
  • Absence of proper suspension of the anticoagulant/antiplatelet therapy prior to procedure according to usual pre-procedure recommendations (BSG and ESGE guidelines)
  • Patients with severe thrombopenia/ coagulopathy (Platelets < 50,000/INR > 1.5) not corrected prior to procedure (plasma or platelet transfusion)
  • Patients not candidates for endoscopic resection of colorectal lesions by comorbidities.
  • Pregnant.
  • Patients with inflammatory bowel disease (IBD)
  • Urgent colonoscopy.
  • Poor preparation (BBPS <2 in the colon segment where the lesion is located)
  • Laterally spreading tumors (LST) lesions with non-homogeneous morphology including: sessile polyps (0-Is), pedunculated (0-Ip) and LST lesions with depressed or excavated components (Paris 0-IIc or Paris 0-III), LST granular nodular mixed, LST-G with whole nodular type. In case of doubt depressed component (Paris 0-IIc) or histological borderline lesion (JNET2B), will be excluded from the study.
  • Histological prediction of deep invasive or non-subsidiary to endoscopic mucosal resection lesion as a treatment of choice: NICE 3 pattern by inspection with NBI or Kudo V pattern in traditional/electronic chromoendoscopy or Sano IIIA/IIIB pattern
  • Endoscopic resection of post-EMR scar level relapses

Sites / Locations

  • Óscar Nogales Rincón

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Standard Endoscopic Mucosal Resection

Cold Snare Endoscopic Mucosal Resection

Arm Description

Standard Endoscopic Mucosal Resection, if necessary, multi-piece to resect large nonpedunculated homogeneous colorectal lesions (>20 mm)

Cold Snare Endoscopic Mucosal Resection, if necessary, multi-piece to resect large nonpedunculated homogeneous colorectal lesions (>20 mm)

Outcomes

Primary Outcome Measures

Complete resection of the lesion
Complete resection of the lesion is defined as the non-visualization by the endoscopist of a residual lesion in the mucosal defect and its edge at the end of the EMR and no visualization of recurrence in the post-EMR scar on the first surveillance colonoscopy and absence of recurrence data in scar biopsies

Secondary Outcome Measures

Security profile
Security profile is defined as the observed percentage of complications (Intra-procedure bleeding, deferred bleeding, deferred bleeding in antiplatelet and/or anticoagulated patients,post-polypectomy fever, post-polypectomy syndrome, deep muscle damage and perforation) in each of the evaluated techniques.
Late adenoma recurrence rate
Late adenoma recurrence rate as determined by endoscopic assessment (no visible recurrent adenoma) and histological assessment (scar biopsies) in surveillance colonoscopy at 18 months of the procedure
Number of fragments needed to complete the resection
Number of fragments needed to resect with polypectomy snare to complete the resection of the colorectal lesion.
Resection time
Time needed to perform endoscopic mucosal resection measured from first snare positioning until complete resection is achieved based on endoscopic assessment.
Bloc resection rate
Number of lesions that have undergone resection in a single fragment with each of these evaluated techniques.
R0 resection rate
Number of lesions with complete macroscopic resection with a negative microscopic margin in the mucosectomy specimen
EMR technique conversion rate
Number of lesions to be finally resected with the other arm of study technique not initially assigned
Need for additional treatments to complete the resection.
Number of lesions that cannot be completely resected with the assigned EMR technique, requiring different techniques to complete the resection, such as SOFT coagulation with snare tip, APC (argon plasma coagulation), hot avulsion with hot biopsy forceps, biopsy forceps, biopsy forceps +ablation
Number of clips used
Number of clip used for hemostatic purposes or for the prophylactic closure of the injury
Degree of artifact/interference in the histological interpretation
Subjective impression of the artifact in the histological interpretation of the resected sample (null, moderate, severe)
Depth of the resected submucosa
Measure the depth of the resected submucosa layer (in microns) with each of the resection techniques used
Percentage of mucosal muscle present in the mucosal protrusions in the resection defect of cold-EMR.
Assess the percentage of presence of mucosal muscle in biopsies performed on the protrusions present in the resection defect of cold-EMR
Need for surgery for technical failure
Number of lesions that have to be finally resected by surgery due to technical impossibility for their endoscopic resection.
Cost-effectiveness study.
evaluate the cost-effectiveness of each of the endoscopic mucosal resection techniques
Sub-analysis by center participating in the study
A subanalysis of the study results by center will be carried out to rule out significant differences between them

Full Information

First Posted
June 3, 2020
Last Updated
September 25, 2023
Sponsor
Oscar Nogales
Collaborators
Spanish Society of Digestive Endoscopy
search

1. Study Identification

Unique Protocol Identification Number
NCT04418843
Brief Title
Cold EMR Vs Standard EMR for the Treatment of Large Nonpedunculated Homogeneous Colorectal Lesions
Official Title
Cold EMR Vs Standard EMR for the Treatment of Large Nonpedunculated Homogeneous Colorectal Lesions.Randomized and Multicentric Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
June 8, 2020 (Actual)
Primary Completion Date
December 31, 2022 (Actual)
Study Completion Date
March 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Oscar Nogales
Collaborators
Spanish Society of Digestive Endoscopy

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study compares the effectiveness in complete resection (absence of recurrence at 6 months) the two different techniques for performing endoscopic mucosal resection (EMR) of nonpedunculated homogeneous colorectal lesions >20mm
Detailed Description
Colonoscopy is the reference diagnostic test for the study of colon diseases. This procedure also allows the realization of endoscopic therapeutics techniques; thus, endoscopic mucosal resection (EMR) is an effective and safe therapy for the treatment of premalignant and early malignant colorectal lesions of the colon and its use is universal. Usually, colon lesions larger than 10 mm (or pedunculated of any size) require for resection the use of electrocoagulation current (or hot snare polypectomy) and thus is reflected in the most recent clinical practice guidelines (ESGE guidelines, for example). However, the risk of side adverse effects from the use of electrocoagulation is not insignificant and includes post-polypectomy bleeding, post-polypectomy syndrome, post-polypectomy fever and/or immediate or delayed perforation. This risk of complications is higher depending on the characteristics and size of colorectal lesions resected. On the other hand, currently in small lesions not pedunculated (< 10 mm), it is recommended to use cold snare polypectomy according to ESGE clinical guidelines, as it has been seen in previous studies that this reduces complication rates without varying the effectiveness in resection. However, in lesions > 10 mm the previous experience with cold snare resection is less, probably motivated by the possible drawbacks in terms of the possible difficulty of resection of thick tissue with cold snare and a possible increased intra-procedure hemorrhagic risk that can make it difficult to see the scar, with the possibility of leaving residual tissue. However, in recent years the accumulated evidence gathered in various studies and grouped in a recent systematic review suggests that endoscopic mucosal resection with cold snare (Cold-EMR) may be safer than electrocoagulation resection for both 10-19mm lesions and for lesions >20 mm, associated with a lower rate of adverse effects with similar efficacy rates in terms of complete resection and adenomatous recurrence rate. Still, evidence for the treatment of nonpedunculated lesions >20 mm is relatively limited and is not based on randomized comparative studies with the standard EMR technique.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adenoma Colon, Serrated Polyp, Serrated Adenoma, Colorectal Neoplasms
Keywords
endoscopic mucosal resection, cold snare endoscopic mucosal resection, standard endoscopic mucosal resection, large nonpedunculated homogeneous colorectal lesions, adenoma colon, serrated polyp, serrated adenoma, conventional endoscopic mucosal resection, laterally spreading adenomas.

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective randomized study (1:1), multicenter, non-blind of consecutive non-pedunculated lesions of serrated and adenomatous histology, homogeneous, with a size greater than or equal to 20 mm (no upper limit in size). Performing cold-EMR vs standard EMR. A non-inferiority study of cold-EMR versus standard EMR.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
229 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard Endoscopic Mucosal Resection
Arm Type
Experimental
Arm Description
Standard Endoscopic Mucosal Resection, if necessary, multi-piece to resect large nonpedunculated homogeneous colorectal lesions (>20 mm)
Arm Title
Cold Snare Endoscopic Mucosal Resection
Arm Type
Experimental
Arm Description
Cold Snare Endoscopic Mucosal Resection, if necessary, multi-piece to resect large nonpedunculated homogeneous colorectal lesions (>20 mm)
Intervention Type
Procedure
Intervention Name(s)
Standard Endoscopic Mucosal Resection
Other Intervention Name(s)
Standard EMR
Intervention Description
Use of injected colloidal or saline solution to raise a lesion prior to polypectomy snare closed over a polyp with electrocautery
Intervention Type
Procedure
Intervention Name(s)
Cold Snare Endoscopic Mucosal Resection
Other Intervention Name(s)
Cold EMR
Intervention Description
Use of injected colloidal or saline solution to raise a lesion prior to polypectomy snare closed over a polyp without electrocautery
Primary Outcome Measure Information:
Title
Complete resection of the lesion
Description
Complete resection of the lesion is defined as the non-visualization by the endoscopist of a residual lesion in the mucosal defect and its edge at the end of the EMR and no visualization of recurrence in the post-EMR scar on the first surveillance colonoscopy and absence of recurrence data in scar biopsies
Time Frame
3-6 months
Secondary Outcome Measure Information:
Title
Security profile
Description
Security profile is defined as the observed percentage of complications (Intra-procedure bleeding, deferred bleeding, deferred bleeding in antiplatelet and/or anticoagulated patients,post-polypectomy fever, post-polypectomy syndrome, deep muscle damage and perforation) in each of the evaluated techniques.
Time Frame
30 days
Title
Late adenoma recurrence rate
Description
Late adenoma recurrence rate as determined by endoscopic assessment (no visible recurrent adenoma) and histological assessment (scar biopsies) in surveillance colonoscopy at 18 months of the procedure
Time Frame
18 months
Title
Number of fragments needed to complete the resection
Description
Number of fragments needed to resect with polypectomy snare to complete the resection of the colorectal lesion.
Time Frame
1 day
Title
Resection time
Description
Time needed to perform endoscopic mucosal resection measured from first snare positioning until complete resection is achieved based on endoscopic assessment.
Time Frame
1 day
Title
Bloc resection rate
Description
Number of lesions that have undergone resection in a single fragment with each of these evaluated techniques.
Time Frame
1
Title
R0 resection rate
Description
Number of lesions with complete macroscopic resection with a negative microscopic margin in the mucosectomy specimen
Time Frame
1 day
Title
EMR technique conversion rate
Description
Number of lesions to be finally resected with the other arm of study technique not initially assigned
Time Frame
1 day
Title
Need for additional treatments to complete the resection.
Description
Number of lesions that cannot be completely resected with the assigned EMR technique, requiring different techniques to complete the resection, such as SOFT coagulation with snare tip, APC (argon plasma coagulation), hot avulsion with hot biopsy forceps, biopsy forceps, biopsy forceps +ablation
Time Frame
1 day
Title
Number of clips used
Description
Number of clip used for hemostatic purposes or for the prophylactic closure of the injury
Time Frame
1 day
Title
Degree of artifact/interference in the histological interpretation
Description
Subjective impression of the artifact in the histological interpretation of the resected sample (null, moderate, severe)
Time Frame
1 day
Title
Depth of the resected submucosa
Description
Measure the depth of the resected submucosa layer (in microns) with each of the resection techniques used
Time Frame
1 day
Title
Percentage of mucosal muscle present in the mucosal protrusions in the resection defect of cold-EMR.
Description
Assess the percentage of presence of mucosal muscle in biopsies performed on the protrusions present in the resection defect of cold-EMR
Time Frame
1 day
Title
Need for surgery for technical failure
Description
Number of lesions that have to be finally resected by surgery due to technical impossibility for their endoscopic resection.
Time Frame
6 months
Title
Cost-effectiveness study.
Description
evaluate the cost-effectiveness of each of the endoscopic mucosal resection techniques
Time Frame
18 months
Title
Sub-analysis by center participating in the study
Description
A subanalysis of the study results by center will be carried out to rule out significant differences between them
Time Frame
18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients of age > 18 years undergoing a colonoscopy for any reason of request and who do not meet exclusion criteria. Nonpedunculated homogeneous colorectal lesions type LST ( Paris 0-IIa morphology) and serrated lesions larger than 20 mm without endoscopic data of malignancy: NICE 1 pattern +/- NICE 2 component ( serrated lesions) or NICE2 pattern/JNET 2A (adenomas) and therefore subsidiaries of RME. Randomization will be performed per patient, not for colorectal lesions Signature of informed consent of endoscopic exploration Exclusion Criteria: .No signature of informed consent prior to the study procedure. Absence of proper suspension of the anticoagulant/antiplatelet therapy prior to procedure according to usual pre-procedure recommendations (BSG and ESGE guidelines) Patients with severe thrombopenia/ coagulopathy (Platelets < 50,000/INR > 1.5) not corrected prior to procedure (plasma or platelet transfusion) Patients not candidates for endoscopic resection of colorectal lesions by comorbidities. Pregnant. Patients with inflammatory bowel disease (IBD) Urgent colonoscopy. Poor preparation (BBPS <2 in the colon segment where the lesion is located) Laterally spreading tumors (LST) lesions with non-homogeneous morphology including: sessile polyps (0-Is), pedunculated (0-Ip) and LST lesions with depressed or excavated components (Paris 0-IIc or Paris 0-III), LST granular nodular mixed, LST-G with whole nodular type. In case of doubt depressed component (Paris 0-IIc) or histological borderline lesion (JNET2B), will be excluded from the study. Histological prediction of deep invasive or non-subsidiary to endoscopic mucosal resection lesion as a treatment of choice: NICE 3 pattern by inspection with NBI or Kudo V pattern in traditional/electronic chromoendoscopy or Sano IIIA/IIIB pattern Endoscopic resection of post-EMR scar level relapses
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oscar Nogales
Organizational Affiliation
Hospital General Universitario Gregorio Marañon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Óscar Nogales Rincón
City
Madrid
ZIP/Postal Code
28007
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30639542
Citation
Thoguluva Chandrasekar V, Spadaccini M, Aziz M, Maselli R, Hassan S, Fuccio L, Duvvuri A, Frazzoni L, Desai M, Fugazza A, Jegadeesan R, Colombo M, Dasari CS, Hassan C, Sharma P, Repici A. Cold snare endoscopic resection of nonpedunculated colorectal polyps larger than 10 mm: a systematic review and pooled-analysis. Gastrointest Endosc. 2019 May;89(5):929-936.e3. doi: 10.1016/j.gie.2018.12.022. Epub 2019 Jan 9.
Results Reference
background
PubMed Identifier
24125514
Citation
Horiuchi A, Nakayama Y, Kajiyama M, Tanaka N, Sano K, Graham DY. Removal of small colorectal polyps in anticoagulated patients: a prospective randomized comparison of cold snare and conventional polypectomy. Gastrointest Endosc. 2014 Mar;79(3):417-23. doi: 10.1016/j.gie.2013.08.040. Epub 2013 Oct 11.
Results Reference
background
PubMed Identifier
26634041
Citation
Takeuchi Y, Yamashina T, Matsuura N, Ito T, Fujii M, Nagai K, Matsui F, Akasaka T, Hanaoka N, Higashino K, Iishi H, Ishihara R, Thorlacius H, Uedo N. Feasibility of cold snare polypectomy in Japan: A pilot study. World J Gastrointest Endosc. 2015 Nov 25;7(17):1250-6. doi: 10.4253/wjge.v7.i17.1250.
Results Reference
background
PubMed Identifier
25141316
Citation
Aslan F, Camci M, Alper E, Akpinar Z, Arabul M, Celik M, Unsal B. Cold snare polypectomy versus hot snare polypectomy in endoscopic treatment of small polyps. Turk J Gastroenterol. 2014 Jun;25(3):279-83. doi: 10.5152/tjg.2014.5085.
Results Reference
background
PubMed Identifier
29169195
Citation
Tate DJ, Awadie H, Bahin FF, Desomer L, Lee R, Heitman SJ, Goodrick K, Bourke MJ. Wide-field piecemeal cold snare polypectomy of large sessile serrated polyps without a submucosal injection is safe. Endoscopy. 2018 Mar;50(3):248-252. doi: 10.1055/s-0043-121219. Epub 2017 Nov 23.
Results Reference
background
PubMed Identifier
28160332
Citation
Hirose R, Yoshida N, Murakami T, Ogiso K, Inada Y, Dohi O, Okayama T, Kamada K, Uchiyama K, Handa O, Ishikawa T, Konishi H, Naito Y, Fujita Y, Kishimoto M, Yanagisawa A, Itoh Y. Histopathological analysis of cold snare polypectomy and its indication for colorectal polyps 10-14 mm in diameter. Dig Endosc. 2017 Jul;29(5):594-601. doi: 10.1111/den.12825. Epub 2017 May 17.
Results Reference
background
PubMed Identifier
29742770
Citation
Rameshshanker R, Tsiamoulos Z, Latchford A, Moorghen M, Saunders BP. Resection of large sessile serrated polyps by cold piecemeal endoscopic mucosal resection: Serrated COld Piecemeal Endoscopic mucosal resection (SCOPE). Endoscopy. 2018 Jul;50(7):E165-E167. doi: 10.1055/a-0599-0346. Epub 2018 May 9. No abstract available.
Results Reference
background
PubMed Identifier
25851161
Citation
Rex KD, Vemulapalli KC, Rex DK. Recurrence rates after EMR of large sessile serrated polyps. Gastrointest Endosc. 2015 Sep;82(3):538-41. doi: 10.1016/j.gie.2015.01.025. Epub 2015 Apr 4.
Results Reference
background
PubMed Identifier
30176072
Citation
Qu J, Jian H, Li L, Zhang Y, Feng B, Li Z, Zuo X. Effectiveness and safety of cold versus hot snare polypectomy: A meta-analysis. J Gastroenterol Hepatol. 2019 Jan;34(1):49-58. doi: 10.1111/jgh.14464. Epub 2018 Sep 26.
Results Reference
background
PubMed Identifier
28114689
Citation
Veitch AM, Vanbiervliet G, Gershlick AH, Boustiere C, Baglin TP, Smith LA, Radaelli F, Knight E, Gralnek IM, Hassan C, Dumonceau JM. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy. 2016 Apr;48(4):c1. doi: 10.1055/s-0042-122686. Epub 2017 Jan 23. No abstract available.
Results Reference
background
PubMed Identifier
27464708
Citation
Burgess NG, Bassan MS, McLeod D, Williams SJ, Byth K, Bourke MJ. Deep mural injury and perforation after colonic endoscopic mucosal resection: a new classification and analysis of risk factors. Gut. 2017 Oct;66(10):1779-1789. doi: 10.1136/gutjnl-2015-309848. Epub 2016 Jul 27.
Results Reference
background
PubMed Identifier
29944582
Citation
Takayanagi D, Nemoto D, Isohata N, Endo S, Aizawa M, Utano K, Kumamoto K, Hojo H, Lefor AK, Togashi K. Histological Comparison of Cold versus Hot Snare Resections of the Colorectal Mucosa. Dis Colon Rectum. 2018 Aug;61(8):964-970. doi: 10.1097/DCR.0000000000001109.
Results Reference
background
PubMed Identifier
31071753
Citation
Rodriguez Sanchez J, Sanchez Alonso M, Pellise Urquiza M. The "bubble sign": a novel way to detect a perforation after cold snare polypectomy. Endoscopy. 2019 Aug;51(8):796-797. doi: 10.1055/a-0881-2856. Epub 2019 May 9. No abstract available.
Results Reference
background
PubMed Identifier
31144663
Citation
Keklikkiran C, Ozdogan OC. Thermal ablation of mucosal defect margins reduces adenoma recurrence after colonic endoscopic mucosal resection. Turk J Gastroenterol. 2019 Jun;30(6):580-581. doi: 10.5152/tjg.2019.210519. No abstract available.
Results Reference
background
PubMed Identifier
24986245
Citation
Moss A, Williams SJ, Hourigan LF, Brown G, Tam W, Singh R, Zanati S, Burgess NG, Sonson R, Byth K, Bourke MJ. Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut. 2015 Jan;64(1):57-65. doi: 10.1136/gutjnl-2013-305516. Epub 2014 Jul 1.
Results Reference
background

Learn more about this trial

Cold EMR Vs Standard EMR for the Treatment of Large Nonpedunculated Homogeneous Colorectal Lesions

We'll reach out to this number within 24 hrs